A bacterial extract of OM-85 Broncho-Vaxom prevents allergic rhinitis in mice

American Journal of Rhinology and Allergy

Volumn 28, Issue 2, 2014, Pages 110-116

  Han, Ling ^a   Zheng, Chao Pan ^a   Sun, Yue Qi ^a   Xu, Geng ^a   Wen, Weiping ^a   Fu, Qing Ling ^a  

^a SUN YAT SEN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIUM LYSATE; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G1; INTERLEUKIN 13; INTERLEUKIN 4; INTERLEUKIN 5; OVALBUMIN; ALLERGEN; BACTERIAL ANTIGEN; BRONCHO-VAXOM; CELL EXTRACT; CYTOKINE; IMMUNOGLOBULIN G; IMMUNOLOGICAL ADJUVANT;

ALLERGIC RHINITIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY BLOOD LEVEL; ARTICLE; BACTERIUM; CELL INFILTRATION; CONTROLLED STUDY; EOSINOPHIL; FEMALE; HYGIENE HYPOTHESIS; IMMUNOMODULATION; INFLAMMATORY CELL; INFLAMMATORY INFILTRATE; LOW DRUG DOSE; MOUSE; NASAL LAVAGE; NONHUMAN; NOSE MUCOSA; NOSE MUCUS; RESPIRATORY TRACT INFECTION; SENSITIZATION; SHORT COURSE THERAPY; TH1 CELL; TH17 CELL; TH2 CELL; TREATMENT DURATION; ANIMAL; ANTIBODY PRODUCTION; BAGG ALBINO MOUSE; BLOOD; CELL CULTURE; DISEASE MODEL; DRUG EFFECTS; HUMAN; IMMUNOLOGY; METABOLISM; MICROBIOLOGY; ORAL DRUG ADMINISTRATION; RHINITIS, ALLERGIC; TIME;

ADJUVANTS, IMMUNOLOGIC; ADMINISTRATION, ORAL; ALLERGENS; ANIMALS; ANTIBODY FORMATION; ANTIGENS, BACTERIAL; CELL EXTRACTS; CELLS, CULTURED; CYTOKINES; DISEASE MODELS, ANIMAL; EOSINOPHILS; FEMALE; HUMANS; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G; IMMUNOMODULATION; MICE; MICE, INBRED BALB C; NASAL MUCOSA; OVALBUMIN; RHINITIS, ALLERGIC; TH1 CELLS; TH2 CELLS; TIME FACTORS;

EID: 84897134581     PISSN: 19458924     EISSN: 19458932     Source Type: Journal    
DOI: 10.2500/ajra.2013.27.4021     Document Type: Article

References (36)

1. Bousquet J, Khaltaev N, Cruz AA, et al. Allergic Rhinitis and Its Impact on Asthma (ARIA) 2008 update (in collaboration with the World Health Organization, GA(2)LEN and AllerGen). Allergy 63(suppl 86):8-160, 2008.
2. Salib RJ, Drake-Lee A, and Howarth PH. Allergic rhinitis: Past, present and the future. Clin Otolaryngol Allied Sci 28:291-303, 2003. (Pubitemid 36960265)
3. Quraishi SA, Davies MJ, and Craig TJ. Inflammatory responses in allergic rhinitis: Traditional approaches and novel treatment strategies. J Am Osteopath Assoc 104:S7-S15, 2004.
4. D'Alonzo GE Jr. Scope and impact of allergic rhinitis. J Am Osteopath Assoc 102:S2-S6, 2002.
5. Barnes PJ. Pathophysiology of allergic inflammation. Immunol Rev 242:31-50, 2011.
6. Orihara K, Dil N, Anaparti V, and Moqbel R. What's new in asthma pathophysiology and immunopathology? Expert Rev Respir Med 4:605-629, 2010.
7. Nauta AJ, Engels F, Knippels LM, et al. Mechanisms of allergy and asthma. Eur J Pharmacol 585:354-360, 2008.
8. Romagnani S. The role of lymphocytes in allergic disease. J Allergy Clin Immunol 105:399-408, 2000. (Pubitemid 30169893)
9. Feng CH, Miller MD, and Simon RA. The united allergic airway: Connections between allergic rhinitis, asthma, and chronic sinusitis. Am J Rhinol Allergy 26:187-190, 2012.
10. Strachan DP. Hay fever, hygiene, and household size. BMJ 299:1259-1260, 1989. (Pubitemid 19280051)
11. Yazdanbakhsh M, Kremsner PG, and van Ree R. Allergy, parasites, and the hygiene hypothesis. Science 296:490-494, 2002.
12. Matricardi PM, Bjorksten B, Bonini S, et al. Microbial products in allergy prevention and therapy. Allergy 58:461-471, 2003. (Pubitemid 36649304)
13. Fiocchi A, Omboni S, Mora R, et al. Efficacy and safety of ribosome-component immune modulator for preventing recurrent respiratory infections in socialized children. Allergy Asthma Proc 33:197-204, 2012.
14. Solèr M, Mütterlein R, and Cozma G; Swiss-German OM-85 Study Group. Double-blind study of OM-85 in patients with chronic bronchitis or mild chronic obstructive pulmonary disease. Respiration 74:26-32, 2007. (Pubitemid 46012445)
15. Schaad UB, Mütterlein R, and Goffin H; BV-Child Study Group. Immunostimulation with OM-85 in children with recurrent infections of the upper respiratory tract: a double-blind, placebo-controlled multicenter study. Chest 122:2042-2049, 2002. (Pubitemid 36051142)
16. Bessler WG, Huber M, and Baier W. Bacterial cell wall components as immunomodulators-II. The bacterial cell wall extract OM-85 BV as unspecific activator, immunogen and adjuvant in mice. Int J Immunopharmacol 19:551-558, 1997. (Pubitemid 28261014)
17. Byl B, Libin M, Gérard M, et al. Bacterial extract OM85-BV induces interleukin-12-dependent IFN-gamma production by human CD4+ T cells. J Interferon Cytokine Res 18:817-821, 1998. (Pubitemid 28489659)
18. Huber M, Mossmann H, and Bessler WG. Th1-orientated immunological properties of the bacterial extract OM-85-BV. Eur J Med Res 10:209-217, 2005. (Pubitemid 40753851)
19. Bowman LM, and Holt PG. Selective enhancement of systemic Th1 immunity in immunologically immature rats with an orally administered bacterial extract. Infect Immun 69:3719-3727, 2001. (Pubitemid 32493290)
20. Navarro S, Cossalter G, Chiavaroli C, et al. The oral administration of bacterial extracts prevents asthma via the recruitment of regulatory T cells to the airways. Mucosal Immunol 4:53-65, 2011.
21. Strickland DH, Judd S, Thomas JA, et al. Boosting airway T-regulatory cells by gastrointestinal stimulation as a strategy for asthma control. Mucosal Immunol 4:43-52, 2011.
22. Sun YQ, Deng MX, He J, et al. Human pluripotent stem cell-derived mesenchymal stem cells prevent allergic airway inflammation in mice. Stem Cells 30:2692-2699, 2012.
23. Hellings PW, Hessel EM, Van Den Oord JJ, et al. Eosinophilic rhinitis accompanies the development of lower airway inflammation and hyper-reactivity in sensitized mice exposed to aerosolized allergen. Clin Exp Allergy 31:782-790, 2001. (Pubitemid 32823824)
24. Yokota E, Kuyama S, Ogawa M, and Kamei C. Substance P is involved in the effect of histamine H3 receptor agonist, Sch 50971 on nasal allergic symptoms in mice. Int Immunopharmacol 8:1083-1088, 2008.
25. Goodwin M, Sueblinvong V, Eisenhauer P, et al. Bone marrow-derived mesenchymal stromal cells inhibit Th2-mediated allergic airways inflammation in mice. Stem Cells 29:1137-1148, 2011.
26. Galli SJ, Tsai M, and Piliponsky AM. The development of allergic inflammation. Nature 454:445-454, 2008.
27. Khan F, Hallstrand TS, Geddes MN, et al. Is allergic disease curable or transferable with allogeneic hematopoietic cell transplantation? Blood 113:279-290, 2009.
28. Qiu H, Kuolee R, Harris G, et al. Acinetobacter baumannii infection inhibits airway eosinophilia and lung pathology in a mouse model of allergic asthma. PLoS One 6:e22004, 2011.
29. Kavanagh H, Noone C, Cahill E, et al. Attenuated Bordetella pertussis vaccine strain BPZE1 modulates allergen-induced immunity and prevents allergic pulmonary pathology in a murine model. Clin Exp Allergy 40:933-941, 2010.
30. Thorburn AN, O'Sullivan BJ, Thomas R, et al. Pneumococcal conjugate vaccine-induced regulatory T cells suppress the development of allergic airways disease. Thorax 65:1053-1060, 2010.
31. Borchers AT, Selmi C, Meyers FJ, et al. Probiotics and immunity. J Gastroenterol 44:26-46, 2009.
32. Razi CH, Harmanci K, Abaci A, et al. The immunostimulant OM-85 BV prevents wheezing attacks in preschool children. J Allergy Clin Immunol 126:763-769, 2010.
33. Barrios C, Brandt C, Berney M, et al. Partial correction of the Th2/Th1 imbalance in neonatal murine responses to vaccine antigens through selective adjuvant effects. Eur J Immunol 26:2666-2670, 1996. (Pubitemid 26364843)
34. Olszak T, An D, Zeissig S, et al. Microbial exposure during early life has persistent effects on natural killer T cell function. Science 336:489-493, 2012.
35. Malm-Erjefält M, Persson CG, and Erjefält JS. Degranulation status of airway tissue eosinophils in mouse models of allergic airway inflammation. Am J Respir Cell Mol Biol 24:352-359, 2001. (Pubitemid 32228385)
36. Shin JH, Kang JM, Kim SW, et al. Effect of oral tolerance in a mouse model of allergic rhinitis. Otolaryngol Head Neck Surg 142:370-375, 2010.